Home  >  News
  Hemogenyx's subsidiary Immugenyx inks collaboration deal with Janssen Research & Development,   October 16, 2018
  Teva Pharmaceutical launches patient-centric website 'Life Effects' in Europe,   October 16, 2018
  EMA's COMP issues positive opinion on orphan drug status for Santhera's POL6014 to treat cystic fibrosis,   October 16, 2018
  Bayer's Xarelto receives US FDA nod to treat coronary artery disease,   October 15, 2018
  Chinese drug authority accepts Eisai's NDA for Perampanel to treat partial onset seizures,   October 13, 2018
  NPL, Mediso enter breakthrough scientific collaboration,   October 12, 2018
  Carrick Therapeutics in-licenses exclusive worldwide rights to develop and commercialise ovarian cancer drug from BTG,   October 12, 2018
  US FDA lifts clinical hold and accepts IND for CRISPR and Vertex's sickle cell disease drug, CTX001,   October 12, 2018
  Baxter, ASPEN launch “SmartPN” tools to reinforce appropriate use of parenteral nutrition,   October 12, 2018
  Teewinot launches new subsidiary, Canalis Pharmaceuticals,   October 11, 2018
  Chugai Pharma's pertuzumab gets Japanese approval for additional indication of HER2-positive early breast cancer,   October 11, 2018
  NuVasive partners with Biedermann Technologies to access IP and co-develop state-of-the-art complex spine solutions,   October 10, 2018
  Therapeutic ADC market likely to reach $4 billion by 2023: CPhI Annual Report,   October 10, 2018
  Novan, Sato expand nitric oxide dermatology business partnership,   October 10, 2018
  BioIVT acquires UK-based Clinical Trials Laboratory Services,   October 10, 2018
  eTheRNA opens mRNA manufacturing facility in Belgium to support production of mRNA cancer immunotherapies,   October 09, 2018
  Atlas Genetics renamed as Binx Health,   October 09, 2018
  US FDA committee to review Mallinckrodt's abuse-deterrent, immediate-release reformulation of Roxicodone NDA,   October 09, 2018
  US FDA & EMA accept Novartis' NDA and MAA for once-daily siponimod to treat SPMS in adults,   October 09, 2018
  US FDA approves Tegsedi to treat polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults,   October 08, 2018

Copyright © 2016 Saffron Media Pvt. Ltd |